Spectra for:
A. Sampath, A. Raghupathi Reddy, B. Yakambaram, A. Thirupathi, M. Prabhakar, P. Pratap Reddy, V. Prabhakar Reddy
IMPURITY-III;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-PEHNYL)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE
![IMPURITY-III;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-PEHNYL)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE](/api/compound/7E4w7wYtA7K.png?h=300&w=458 "IMPURITY-III;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-PEHNYL)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE")
IMPURITY-IV;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-4-PENTENOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE
![IMPURITY-IV;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-4-PENTENOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE](/api/compound/5ZR1jty9inv.png?h=300&w=458 "IMPURITY-IV;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-4-PENTENOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE")
IMPURITY-V;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-HYDROXY)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE
![IMPURITY-V;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-HYDROXY)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE](/api/compound/39RwJuLb19W.png?h=300&w=458 "IMPURITY-V;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-HYDROXY)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE")
Valsartan
Citation
| Citation | J.PHARM.BIOM.ANAL.,50,405(2009) |
|---|---|
| Journal | Journal of Pharmaceutical and Biomedical Analysis |
| Issue | 3 |
| Volume | 50 |
| Page(s) | 405-412 |
| Year | 2009 |
| Author(s) | A. Sampath, A. Raghupathi Reddy, B. Yakambaram, A. Thirupathi, M. Prabhakar, P. Pratap Reddy, V. Prabhakar Reddy |
| Publisher | Elsevier BV |
| DOI | 10.1016/j.jpba.2009.05.024 |